Medicago Inc (Medicago) is a clinical-stage biotechnology company. The Company is focused on the development of vaccines using its Virus-Like Particules (VLPs) and manufacturing technologies. Medicago�s VLP manufacturing technology is based on a transient expression system, which produces recombinant vaccine antigens in non-transgenic plants. Medicago operates a 24,000-square-foot production facility located in the Technology Park in Quebec City, Canada. This facility includes a Biosafety level 2 greenhouse, an extraction and purification unit, and is cGMP compliant. The Company�s products include Pandemic flu vaccine and Seasonal flu vaccine. Medicago U.S.A is a wholly owned subsidiary of Medicago.